NEWTOWN, Pa.--(BUSINESS WIRE)--BioClinica®, Inc. (NASDAQ: BIOC), a global provider of clinical trial management solutions, today announced its financial results for the fourth quarter and year ended December 31, 2011.
Financial highlights for the quarter ended December 31, 2011 include:
Service revenues were $18.3 million as compared with $16.5 million for the same period 2010.
